Sees Q3 revenue ~$15.5B, consensus $15.45B.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie says well positioned to deliver in FY25 and beyond
- Morning Movers: Roblox skyrockets following second quarter results
- AbbVie raises FY25 revenue view to $60.5B from ~$59.7B, consensus $60.01B
- AbbVie raises FY25 adjusted EPS view to $11.88-$12.08 from $11.67-$11.87
- AbbVie reports Q2 adjusted EPS $2.97, consensus $2.91